This event is free to attend and open to all in collaboration with PharmaLex.
Speaker Panel:
Julia Price, principal consultant @PharmaLex: Julia has over 30 years of broad-based experience in Regulatory Affairs. For example, experience in a broad number of therapeutic areas such as biologicals particularly in the area of haemophilia, antibacterials, opthalmics, anti-HIV, oncology, immunology and anti-rheumatics. She will be speaking on pathways to accelerate the development/approval of small molecules.
Tony Gomez, Senior Manager @PharmaLex: Tony will present on how Omics analysis can benefit both R&D as well into Regulatory success, when incorporated into therapeutic development programs. He has more than 12 years working as a Bioinformatician analyzing Next Generation Sequencing Genomic Data from several human diseases (Cancer, Immune Mediated Inflammatory Diseases (IMIDs) , Cardiac and Rare diseases, Diabetes,...). High skills in different bioinformatics approaches to cope with methylation, expression, genetic variants, chromatin states…
